Endothelin and subarachnoid hemorrhage: An overview

Neurosurgery

Volumn 43, Issue 4, 1998, Pages 863-875

  Zimmermann, Michael ^a   Seifert, Volker ^b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b NONE

Author keywords

Cerebral vasospasm; Endothelin; Endothelin receptor; Subarachnoid hemorrhage

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN 2; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR ANTAGONIST; ENDOTHELIN CONVERTING ENZYME;

AMINO ACID SEQUENCE; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; ENDOTHELIUM INJURY; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SUBARACHNOID HEMORRHAGE; VASOSPASM;

ANIMALS; BRAIN; ENDOTHELINS; ENDOTHELIUM, VASCULAR; HUMANS; INTRACRANIAL ANEURYSM; ISCHEMIC ATTACK, TRANSIENT; SUBARACHNOID HEMORRHAGE; VASOCONSTRICTION;

EID: 0031781904     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199810000-00083     Document Type: Review

References (150)

1. Alabadi JA, Salom JB, Torregrosa G, Miranda FJ, Jover T, Alborch E: Changes in the cerebrovascular effects of endothelin-1 and nicardipine after experimental subarachnoid hemorrhage. Neurosurgery 33:707-715, 1993.
2. Allen GS: Cerebral arterial spasm. Clin Neurosurg 32:70-78, 1984.
3. Alonso MJ, Salaices M, Sanchez-Ferrer CF, Marin J: Predominant role of nitric oxide in the relaxation induced by acetylcholine in cat cerebral arteries. J Pharmacol Exp Ther 261:12-20, 1992.
4. Ando K, Hirata Y, Shichiri M, Emori T, Marumo F: Presence of immunoreactive endothelin in human plasma. FEBS Lett 245: 164-166, 1989.
5. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S: Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348:730-732, 1990.
6. Asano T, Ikegaki I, Susuki Y, Satoh S, Shibuya M: Endothelin and the production of vasospasm in dogs. Biochem Biophys Res Commun 159:1345-1351, 1989.
7. ++ agonist K 8644: Different vasoconstrictive properties. Biochem Biophys Res Commun 156:186-192, 1988.
8. Ayajiki K, Okamura T, Toda N: Involvement of nitric oxide in endothelium-dependent phasic relaxation caused by histamine in monkey cerebral arteries. Jpn J Physiol 60:357-362, 1992.
9. Bauknight GC, Faraci FM, Heistad DD: Endothelium-derived relaxing factor modulates noradrenergic constriction of cerebral arterioles in rabbits. Stroke 23:1522-1526, 1992.
10. Boulanger C, Lüscher TF: Release of endothelin from porcine aorta: Inhibition by endothelium derived nitric oxide. J Clin Invest 85:587-590, 1990.
11. Breu V, Löffler BM, Clozel M: In vitro characterization of Ro 46-2005, a novel synthetic non-peptide endothelin antagonist of ETA and ETB receptors. FEBS Lett 334:210-214, 1993.
12. Caner HH, Kwan AL, Arthur A, Jeng AY, Lappe RW, Kassell NF, Lee KS: Systemic administration of an inhibitor of endothelin-converting enzyme for attenuation of cerebral vasospasm following experimental subarachnoid hemorrhage. J Neurosurg 85:917-922, 1996.
13. Cernacek P, Steward DJ: Immunoreactive endothelin in human plasma: Marked elevations in patients in cardiogenic shock. Biochem Biophys Res Commun 161:562-567, 1989.
14. Chabrier PE, Braquet P: Endothelin. Horm Res 34:169-174, 1990.
15. Clozel M, Watanabe H: BQ-123, a peptidic endothelin receptor antagonist, prevents the early cerebral vasospasm following subarachnoid hemorrhage after intracisternal but not intravenous injection. Life Sci 52:825-834, 1993.
16. Clozel M, Breu V, Burri K, Cassel JM, Fischli W, Gray GA, Hirth G, Löffler BM, Müller M, Neidhart W, Ramuz H: Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature 365:759-761, 1993.
17. Clozel M, Breu V, Gray CA, Kalina B, Löffler BM, Burri K, Cassal JM, Hirth G, Müller M, Neidhart W, Ramuz H: Pharmacological characterization of bosentan, a new potent orally active nonpeptidic endothelin receptor antagonist. J Pharmacol Exp Ther 270: 228-235, 1994.
18. B receptor mediates both vasodilatation and vasoconstriction in vivo. Biochem Biophys Res Commun 186:867-873, 1992.
19. Cocks T, Malta E, King S, Woods R, Angus J: Oxyhaemoglobin increases the production of endothelin-1 by endothelial cells in culture. Eur J Pharmacol 196:177-182, 1991.
20. Cornet S, Braillon A, Guilmard C, Chabrier PE, Pirotzky E, Braquet P: Involvement of endothelin in renal processes. Hypertension 15:724-728, 1990.
21. Cosentino F, McMahon EG, Carter JS, Katusic ZS: Effect of endothelin-A- receptor antagonist BQ-123 and phosphoramidon on cerebral vasospasm. J Cardiovasc Pharmacol 22[Suppl 8]:332-335, 1993.
22. Cosentino F, Sill JC, Katusic ZS: Endothelial L-arginine pathway and relaxations to vasopressin in canine basilar artery. Am J Physiol 264:H413-H418, 1993.
23. Cozza EN, Gomez-Sanchez CE, Foecking MF, Chiou S: Endothelin binding to cultured calf adrenal zona glomerulosa cells and stimulation of aldosterone secretion. J Clin Invest 84:1032-1035, 1989.
24. Davenport AP, O'Reilly G, Molenaar P, Maguire JJ, Kuc RE, Sharkey A, Bacon CR, Ferro A: Human endothelin receptors characterized using reverse transcriptase-polymerase chain reaction, in-situ hybridization and subtype selective ligands BQ123 and BQ3020: Evidence for expression of ET-B receptors in human vascular smooth muscle. J Cardiovasc Pharmacol 22[Suppl 8]:22-25, 1993.
25. De Nucci G, Thomas R, D'Orleans-Juste P, Antunes E, Walder C, Warner TD, Vane JR: Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci U S A 85:9797-9800, 1988.
26. Ehrenreich H, Anderson RW, Fox CH, Rieckmann P, Hoffman GS, Travis WD, Coligan JE, Kehrl JH, Fauci AS: Endothelins, peptides with potent vasoactive properties, are produced by human macrophages. J Exp Med 172:1741-1748, 1990.
27. Ehrenreich H, Kehrl JH, Anderson W, Rieckmann P, Vitkovic L, Coligan JE, Fauci AS: A vasoactive peptide, endothelin-3, is produced by and specifically binds to primary astrocytes. Brain Res 538:54-58, 1991.
28. Ehrenreich H, Lange M, Near KA, Anneser F, Schoeller LAC, Schmid R, Winkler PA, Kehrl JH, Schmiedek P, Goebel FD: Long-term monitoring of immunoreactive endothelin-1 and endothelin-3 in ventricular cerebrospinal fluid, plasma and 24-h urine of patients with subarachnoid hemorrhage. Res Exp Med (Berl) 192:257-268, 1992.
29. Faraci FM, Heistad DD: Endothelium-derived relaxing factor inhibits constrictor response of large cerebral arteries to serotonin. J Cereb Blood Flow Metab 12:500-506, 1992.
30. Faraci FM, Lopez JAG, Breese KR, Armstrong ML, Heistad DD: Effect of artherosclerosis on cerebral vascular response to activation of leukocytes and platelets in monkeys. Stroke 22:790-796, 1991.
31. Faraci FM, Williams JK, Breese KR, Armstrong ML, Heistad DD: Atherosclerosis potentiates constrictior responses of cerebral and ocular blood vessels to thromboxane. Stroke 20:242-247, 1989.
32. Fein FS, Factor SM, Cho S, Miller-Green B, Carroll DW, Sonnenblick EH: Catecholamine-induced myocardial necrosis in experimental diabetes mellitus. Arch Pathol Lab Med 107:480-483, 1983.
33. Fisher CM, Kistler JP, Davis JM: Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 6:1-9, 1980.
34. Foley PL, Caner HH, Kassell NF, Lee KS: Reversal of subarachnoid hemorrhage-induced vasoconstriction with an endothelin receptor antagonist. Neurosurgery 34:108-113, 1994.
35. Fujimori A, Yanagisawa M, Saito A, Goto K, Masaki T, Mima T, Takakura K, Shigeno T: Endothelin in plasma and cerebrospinal fluid of patients with subarachnoid hemorrhage. Lancet 336:633, 1989 (letter).
36. Fujiwara S, Kassell NF, Sasaki T, Nakagomi T, Lehman RM: Selective hemoglobin inhibition of endothelium-dependent vasodilation of rabbit basilar artery. J Neurosurg 64:445-152, 1986.
37. Fukuroda T, Nishikibe M, Ohta Y, Ihara M, Yano M, Ishikawa K, Fukami T, Ikemoto F: Analysis of responses to endothelin in isolated porcine blood vessels by using a novel endothelin antagonist, BQ 123. Life Sci 50:107-112, 1992.
38. Furchtgott RF, Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373-376, 1980.
39. Giaid A, Gibson SJ, Ibrahim NBN, Legon S, Bloom SR, Yanagisawa M, Masaki T, Varndell IM, Polak JM: Endothelin-1, an endothelium-derived peptide, is expressed in neurons of the human spinal cord and the dorsal root ganglia. Proc Natl Acad Sci U S A 86:7634-7638, 1989.
40. Goetz KL, Wang BC, Madwed JB, Zhu JL, Leadley RJ: Cardiovascular, renal, and endocrine responses to intravenous endothelin in conscious dogs. Am J Physiol 255:1064-1068, 1988.
41. Gonzalez C, Estrada C: Nitric oxide mediates the neurogenic vasodilatation of bovine cerebral arteries. J Cereb Blood Flow Metab 11:366-370, 1992.
42. 2+ channel in vascular smooth muscle. Proc Natl Acad Sci U S A 86:3915-3918, 1989.
43. Gu XH, Liu JJ, Dillon JS, Naylor WG: The failure of endothelin to displace bound, radioactively labeled, calcium antagonists (PN200/110, D888 and diltiazem). Br J Pharmacol 96:262-264, 1989.
44. Haddon WS, Prough DS, Kong D, Petrozza P: Effects of nimodipine on the production of thromboxane A2 following total global cerebral ischemia. J Neurosurg 69:416-420, 1988.
45. Hardebo JE, Kahrstrom J, Owman C: P1 and P2 purine receptors in brain circulation. Eur J Pharmacol 144:343-352, 1987.
46. Harrison VJ, Randriantsoa A, Schoeffter P: Heterogenity of endothelin-sarafotoxin receptors mediating contraction of pig coronary artery. Br J Pharmacol 105:511-513, 1992.
47. Heistad DD, Breese K, Armstrong ML: Cerebral vasoconstrictor responses to serotonin after dietary treatment for transient ischemic stroke. Stroke 18:1068-1073, 1987.
48. Hino A, Tokuyama Y, Kobayashi M, Yano M, Weir BKA, Takeda J, Wang X, Bell GI, Macdonald RL: Increased expression of endothelin B receptor mRNA following subarachnoid hemorrhage in monkeys. J Cereb Blood Flow Metab 16:688-697, 1996.
49. Hino A, Weir BKA, MacDonald RL, Thisted RA, Kim CJ, Johns LM: Prospective, randomized, double-blind trial of BQ 123 and bosentan for prevention of vasospasm following subarachnoid hemorrhage in monkeys. J Neurosurg 83:503-509, 1995.
50. Hirata Y, Yoshimi H, Takata S, Watanabe TX, Kumagai S, Nakajima K, Sakakibara S: Cellular mechanism of action by a novel vasoconstrictor endothelin in cultured rat vascular smooth muscle cells. Biochem Biophys Res Commun 154:868-875, 1988.
51. Hori S, Komatsu Y, Shigemoto R, Mizumi N, Nakanishi S: Distinct tissue distribution and cellular localization of two messenger ribonucleic acids encoding different subtypes of rat endothelin receptors. Endocrinology 130:1885-1895, 1992.
52. Hunt WE, Hess RM: Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 28:14-19, 1968.
53. Ide K, Yamakawa K, Nakagomi T, Sasaki T, Saito I, Kurihara H, Yoshizumi M, Yazaki Y, Takakura K: The role of endothelin in the pathogenesis of vasospasm following subarachnoid hemorrhage. Neurol Res 11:101-104, 1989.
54. Ihara M, Noguchi K, Saeki T, Fukuroda T, Tsuchida S, Kimura S, Fukami T, Ishikawa K, Nishikibe M, Yano M: Biological profiles of highly potent novel endothelin antagonists selective for endothelin ET-A receptor. Life Sci 50:247-255, 1992.
55. Ishikawa T, Yanagisawa M, Kimura S, Goto K, Masaki T: Positive inotropic action of novel vasoconstrictor peptide endothelin on guinea pig atria. Am J Physiol 255:970-973, 1988.
56. Itoh S, Sasaki T, Asai A, Kuchino Y: Prevention of delayed vasospasm by an endothelin ETA receptor antagonist, BQ-123: Change of ETA receptor mRNA expression in a canine subarachnoid hemorrhage model. J Neurosurg 81:759-764, 1994.
57. Itoh S, Sasaki T, Die K, Ishikawa K, Nishikibe M, Yano M: A novel ETA receptor antagonist, BQ-485, and its preventive effect on experimental cerebral vasospasm in dogs. Biochem Biophys Res Commun 195:969-975, 1993.
58. Jansen I, Alafaci C, McCulloch J, Uddman R, Edvisson L: Tachykinins (Substance P, neuropeptide K, and neurokinin B) in the cerebral circulation: Vasomotor responses in vitro and in situ. J Cereb Blood Flow Metab 11:567-575, 1991.
59. Kassell NF, Torner JC: Aneurysmal rebleeding: A preliminary report from the Cooperative Aneurysm Study. Neurosurgery 13:479-481, 1983.
60. Kassell NF, Sasaki T, Colohan ART, Nazar G: Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 16:562-572, 1985.
61. Kassell NF, Torner JC, Haley EC, Jane JA, Adams HP, Kongable GL: The international cooperative study on the timing of aneurysm surgery: Part 1 - Overall management results. J Neurosurg 73:18-36, 1990.
62. Kasuya H, Weir BKA, White DM, Stefanson K: Mechanism of oxyhemoglobin-induced release of endothelin-1 from cultured vascular endothelial cells and smooth muscle cells. J Neurosurg 79:892-898, 1993.
63. Katusic ZS: Endothelial L-arginine pathway and cerebral arterial reactivity to vasopressin. Am J Physiol 262:1557-1562, 1992.
64. Katusic ZS, Milde JH, Cosentino F, Mitrovic BS: Subarachnoid hemorrhage and endothelial L-arginine pathway in small brain stem arteries. Stroke 24:392-399, 1993.
65. Katusic ZS, Shepherd JT, Vanhoutte PM: Vasopressin causes endothelium-dependent relaxation of canine basilar artery. Circ Res 55:575-579, 1984.
66. 2α-induced endothelium-dependent relaxation in isolated monkey cerebral arteries. Am J Physiol 260:1538-1543, 1991.
67. Kim P, Schini VB, Sundt TM Jr, Vanhoutte PM: Reduced production of cGMP underlies the loss of endothelium-dependent relaxations in the canine basilar artery after subarachnoid hemorrhage. Circ Res 70:248-256, 1992.
68. Kloog Y, Sokolowsky M: Similarities in mode and sites of action of sarafotoxins and endothelins. Trends Pharmacol Sci 10:212-214, 1989.
69. Kobayashi H, Hayashi M, Kobayashi S, Kabuto M, Handa Y, Kawano H: Effect of Endothelin on the canine basilar artery. Neurosurgery 27:357-361, 1990.
70. Kobayashi H, Hayashi M, Kobayashi S, Kabuto M, Handa Y, Kawano H, Ide H: Cerebral vasospasm and vasoconstriction caused by endothelin. Neurosurgery 28:673-678, 1991.
71. 125I] BQ-3020, reveals the localization of endothelin ET-B receptors. Eur J Pharmacol 235:95-100, 1993.
72. Kontos HE, Wei EP, Povlishock JT, Dietrich WD, Magiera CJ, Ellis EF: Cerebral arteriolar damage by arachidonic acid and prostaglandin G2. Science 209:1242-1245, 1980.
73. Koyama H, Nishzawa Y, Morii H, Tabata T, Inoue T, Yamaji T: Plasma endothelin levels in patients with uraemia. Lancet 1:991-992, 1989.
74. Kraus G, Bucholz R, Yoon K, Knüpfer M, Smith K: Cerebrospinal fluid endothelin-1 and endothelin-3 levels in normal and neurosurgical patients: A clinical study and literature review. Surg Neurol 35:20-29, 1991.
75. Lagente V, Chabrier PE, Mencia-Huerta JM, Braquet P: Aerosol administration of endothelin induces bronchoconstriction in the guinea pig. Biochem Biophys Res Commun 158:625-632, 1989.
76. Lee ME, de la Monte SM, Ng SC, Bloch DB, Quertermous T: Expression of the potent vasoconstrictor endothelin in the human central nervous system. J Clin Invest 86:141-147, 1990.
77. Le Monnier de Gouville AC, Lippton HL, Cavero I, Summer WR, Hyman AL: Endothelin: A new family of endothelium derived peptides with widespread biological properties. Life Sci 45: 1499-1513, 1989.
78. MacCumber MW, Ross CA, Snyder SH: Endothelin in brain: Receptors, mitogenesis, and biosynthesis in glial cells. Proc Natl Acad Sci U S A 87:2359-2363, 1990.
79. Macdonald RL, Weir BKA: A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 22:971-982, 1991.
80. Masaoka H, Susuki R, Hirata Y, Emori T, Marumo F, Hirakawa K: Raised plasma endothelin in aneurysmal subarachnoid hemorrhage. Lancet 336:1402, 1989 (letter).
81. Matsumura Y, Ikegawa R, Susuki Y, Takaoka M, Uchida T, Kido H, Shinyama H, Hayashi K, Watanabe K, Morimoto S: Phosphoramidon prevents cerebral vasospasm following subarachnoid hemorrhage in dogs: The relationship to endothelin-1 levels in the cerebrospinal fluid. Life Sci 49:841-848, 1991.
82. Matsumura Y, Ikegawa R, Tsukahara Y, Takaoka M, Morimoto S: Conversion of big endothelin-1 to endothelin-1 by two types of metalloproteinases derived from porcine aortic endothelial cells. FEBS Lett 272:166-170, 1990.
83. McMahon EG, Fok KF, Moore WM, Smith CE, Siegel NR, Trapani AJ: In vitro and in vivo activity of chymotrypsin activated big-endothelin (porcine 1-40). Biochem Biophys Res Commun 161:406-413, 1989.
84. Miller WL, Redfield MM, Burnett JC: Integrated cardiac, renal, and endocrine actions of endothelin. J Clin Invest 83:317-320, 1989.
85. Mima T, Yanagisawa M, Shigeno T, Saito A, Goto K, Takakura K, Masaki T: Endothelin acts in feline and canine cerebral arteries from the adventitial side. Stroke 20:1553-1556, 1989.
86. Miyauchi T, Yanagisawa M, Tomizawa T: Increased plasma concentrations of endothelin-1 and big endothelin-1 in acute myocardial infarction. Lancet 2:53-54, 1989.
87. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109-142, 1991.
88. Moreland S, McMullen DM, Delaney CL, Lee VG, Hunt JT: Venous smooth muscle contains vasoconstrictor ET-B-like receptors. Biochem Biophys Res Commun 184:100-106, 1992.
89. Naylor WG: Endothelin: Isoforms, binding sites, and possible implications in pathology. Trends Pharmacol Sci 11:96-99, 1990.
90. Nirei H, Hamada K, Shoubo M, Sogabe K, Notsu Y, Ono T: An endothelin ETA receptor antagonist, FR139317, ameliorates cerebral vasospasm in dogs. Life Sci 52:1869-1874, 1993.
91. Ohlstein EH, Storer BL: Oxyhemoglobin stimulation of endothelin production in cultured endothelial cells. J Neurosurg 77:274-278, 1992.
92. Onoda K, Shigeki O, Ogihara K, Shiota T, Asari S, Ohmoto T, Nimomiya Y: Inhibition of vascular contraction by intracisternal administration of preproendothelin-1 mRNA antisense oligoDNA in a rat experimental vasospasm model. J Neurosurg 85:846-852, 1996.
93. Onoue H, Kaito N, Tokudome S, Abe T, Tashibu K, Nagashima H, Nakamura N: Investigation of postmortem functional changes in human cerebral arteries. J Cereb Blood Flow Metab 13:346-349, 1993.
94. Paoletti P, Jonas PE, Grignani G: CSF leukotriene C4 following subarachnoid hemorrhage. J Neurosurg 69:488-493, 1988.
95. Papadopoulos S, Gilbert L, Webb C, Amato C: Characterization of contractile responses to endothelin in human cerebral arteries: Implications for cerebral vasospasm. Neurosurgery 26:810-815, 1990.
96. Pernow J, Hemsen A, Lundberg JM: Increased plasma levels of endothelin-iike immunoreactivity during endotoxin administration in the pig. Acta Physiol Scand 137:317-318, 1989.
97. Pluta RM, Boock RJ, Afshar JK, Clouse K, Bacic M, Ehrenreich H, Oldfield EH: Source and cause of endothelin-1 release into cerebrospinal fluid after subarachnoid hemorrhage. J Neurosurg 87:287-293, 1997.
98. Rakugi H, Nakamaru M, Saito H, Higaki J, Ogihara T: Endothelin inhibits renin release from isolated rat glomerula. Biochem Biophys Res Commun 155:1244-1247, 1988.
99. Randall MD, Douglas SA, Hiley CR: Vascular activities of endothelin-1 and some alanyl-substituted analogues in resistance beds of the rat. Br J Phannacol 98:685-699, 1989.
100. Rodriguez Y, Baena RP, Gaetani G, Grignani G, Pacciarini I: Effect of nimodipine on arachidonic acid metabolites after subarachnoid hemorrhage. Acta Neurol Scand 76:267-271, 1987.
101. Roubert P, Gillard V, Plas P, Chabrier PE, Braquet P: Down-regulation of endothelin binding sites in rat vascular smooth muscle cells. Am J Hypertens 3:310-312, 1990.
102. Roubert P, Gillard V, Plas P, Guillon JM, Chabrier PE, Braquet P: Angiotensin II and phorbol-esters potency down-regulate endothelin (ET-1) binding sites in vascular smooth muscle cells. Biochem Biophys Res Commun 164:809-815, 1989.
103. Roux S, Löffler BM, Gray GA, Sprecher U, Clozel M, Clozel JP: The role of endothelin in experimental cerebral vasospasm. Neurosurgery 37:78-86, 1995.
104. Saida K, Mitsui Y, Ishida N: A novel peptide, vasoactive intestinal contractor of a new (endothelin) peptide family: Molecular cloning, expression, and biological activity. J Biol Chem 264: 14613-14616, 1989.
105. Saito Y, Nakao K, Mukoyama M, Imura H: Increased plasma endothelin levels in patients with essential hypertension. N Eng J Med 322:205, 1990 (letter).
106. Schini VB, Hendrickson H, Heublein DM: Thrombin enhances the release of endothelin from porcine aortic endothelial cells. Eur J Pharmacol 165:333-334, 1989.
107. Seifert V, Eisert W, Stolke D, Goetz C: Efficacy of single intracisternal bolus injection of recombinant tissue plasminogen activator to prevent delayed cerebral vasospasm after experimental subarachnoid hemorrhage. Neurosurgery 25:590-598, 1989.
108. Seifert V, Löffler BM, Zimmermann M, Roux S, Stolke D: Endothelin concentrations in patients with aneurysmal subarachnoid hemorrhage: Correlation with cerebral vasospasm, delayed ischemic neurological deficits, and volume of hematoma. J Neurosurg 82:55-62, 1995.
109. Seifert V, Stolke D, Kaever V, Dietz H: Arachnoidonic acid metabolism following aneurysm rupture. Surg Neurol 27:243-252, 1987.
110. Seifert V, Stolke D, Reale E: Ultrastructural changes of the basilar artery following experimental subarachnoid hemorrhage. Acta Neurochir (Wien) 100:164-171, 1989.
111. Sercombe R, Verrecchia C, Oudart N: Pial artery responses to norepinephrine potentiated by endothelial removal. J Cereb Blood Flow Metab 5:312-317, 1985.
112. Shetty SS, Okada T, Webb RL, Del Grande D, Lappe RW: Functionally distinct endothelin ETB receptors in vascular endothelium and smooth muscle. Biochem Biophys Res Commun 191: 459-464, 1993.
113. Shichiro M, Hirata Y, Kanno K, Ohta K, Emori T, Marumo F: Effect of endothelin-1 on release of arginine-vasopressin from perfused rat hypothalamus. Biochem Biophys Res Commun 163:1332-1337, 1989.
114. Shigeno T, Clozel M, Sakai S, Saito A, Goto K: The effect of bosentan, a newly developed endothelin receptor antagonist, on the pathogenesis of cerebral vasospasm. Neurosurgery 37:87-91, 1995.
115. Shigeno T, Mina T, Yanagisawa M, Saito A, Goto K, Yamashita K, Takenoushi T, Matsuura N, Yamasaki Y, Yamada K, Masaki T, Takakura K: Prevention of cerebral vasospasm by actinomycin D. J Neurosurg 74:940-943, 1991.
116. Shinmi O, Kimura S, Sawamura T, Sugita Y, Yoshizawa T, Uchiyama Y, Yanagisawa M, Goto K, Masaki T, Kanazawa I: Endothelin-3 is a novel neuropeptide: Isolation and sequence determination of endothelin-1 and endothelin-3 in porcine brain. Biochem Biophys Res Commun 164:587-593, 1989.
117. Shinyama H, Uchida T, Kido H, Hayashi K, Watanabe M, Matsumura Y, Ikegawa R, Takaoka M, Morimoto S: Phosphoramidon inhibits the conversion of intracisternally administrated big endothelin to endothelin-1. Biochem Biophys Res Commun 178:24-30, 1991.
118. + exchange, c-fos expression and mitogenesis in rat mesangial cells. J Clin Invest 83:708-712, 1989.
119. Steward DJ, Kubac G, Costello KB, Cernacek P: Increased plasma endothelin-1 in the early hours of acute myocardial infarction. J Am Coll Cardiol 18:38-43, 1991.
120. Sugiura M, Snajdar RM, Schwartzberg M, Badr KF, Inagami T: Identification of two types of specific endothelin receptors in rat mesangial cell. Biochem Biophys Res Commun 162:1396-1401, 1989.
121. Sukurai T, Yanagisawa M, Takuwa Y, Mivazaki H, Kimura S, Goto K, Masaki T: Cloning of a cDNA encoding a non-isopeptide selective subtype of the endothelin receptor. Nature 348:732-735, 1990.
122. Susuki R, Masaoka E, Hirata H, Marumo F, Isotani E, Hirakawa K: The role of endothelin-1 in the origin of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 77:96-100, 1992.
123. Susuki H, Sato S, Susuki Y, Takekoshi K, Ishihara N, Shimoda S: Increased endothelin concentration in CFS from patients with subarachnoid hemorrhage. Acta Neurol Scand 81:553-554, 1990.
124. Susuki H, Sato S, Susuki Y, Tsuchiya T, Yamanaka T, Ino I, Ishohara N, Shimoda S: Endothelin immunoreactivity in cerebrospinal fluid of patients with subarachnoid hemorrhage. Ann Med 22:233-236, 1990.
125. Takaoka M, Takenobu Y, Miyata Y, Ikegawa R, Matsumura Y, Morimoto S: Pepsin, an aspartic protease, converts porcine big endothelin to 21-residue endothelin. Biochem Biophys Res Commun 166:436-442, 1990.
126. Takuwa N, Takuwa Y, Yanagisawa M, Yamashita K, Masaki T: A novel vasoactive peptide, endothelin, stimulates mitogenesis through inositol lipid turnover in Swiss 3T3 fibroblasts. J Biol Chem 264:7856-7861, 1989.
127. Teerlink JR, Breu V, Sprecher U, Clozel M, Clozel JP: Potent vasoconstriction mediated by endothelin ET-B receptors in canine coronary arteries. Circ Res 74:105-114, 1994.
128. Touvay C, Vilain B, Pons F, Chabrier PE, Mencia-Huerta JM, Braquet P: Bronchopulmonary and vascular effect of endothelin in the guinea pig. Eur J Pharmacol 176:23-33, 1990.
129. Trezise DJ, Drew GM, Weston AH: Analysis of the depressant effect of the endothelium on contractions of rabbit isolated basilar artery to 5-hydroxytryptamine. Br L Pharmacol 106:587-592, 1992.
130. Usui H, Kurahashi K, Shirahase H, Manabe K, Shibata S, Fujiwara M: Endothelium-dependent relaxation in monkey cerebral and contraction in canine cerebral arteries produced by histamine. Med Sci Res 17:1035-1036, 1989.
131. Wagner OF, Nowotny P, Vierhapper H, Waldhäusel W: Plasma concentrations of endothelin in man: Arterio-venous differences and release during venous stasis. Eur J Clin Invest 20:502-505, 1989.
132. Warner T, Allcock GH, Mickley EJ, Corder R, Vane JR: Comparative studies with the endothelin receptor antagonist BQ-123 and PD-142893 indicate at least three endothelin receptors. J Cardiovasc Pharmacol 22[Suppl 8]:117-120, 1993.
133. White RP, Robertson J: Pharmacodynamic evaluation of human arteries in the genesis of vasospasm. Neurosurgery 21:523-531, 1987.
134. Wiklund NP, Öhln A, Cederqvist B: Adrenergic neuromodulation by endothelin in guinea pig artery. Neurosci Lett 101:269-273, 1989.
135. Wilkins RH: Cerebral vasospasm. Contemp Neurosurg 10:1-66, 1988.
136. Williams DL Jr, Jones KL, Pettibone DJ, Lis EV, Clineschmidt BV: Sarafotoxin S6c: An agonist which distinguishes between endothelin receptor subtypes. Biochem Biophys Res Commun 175: 556-561, 1991.
137. Winkles JA, Alberts GF, Brogi E, Libby P: ndothelin-1 and endothelin receptor mRNA expression in normal and atherosclerotic human arteries. Biochem Biophys Res Commun 191:1081-1088, 1993.
138. Yamaji T, Johshita H, Ishibashi M: Endothelin family in human plasma and cerebrospinal fluid. J Clin Endocrinol Metab 71: 1611-1615, 1990.
139. Yamamati T, Johshita H, Takaku F, Ohno H, Susuki N, Matsumoto H, Fujino M: Endothelin family in human plasma and cerebrospinal fluid. J Clin Endocrinol Metab 71:1611-1615, 1990.
140. Yamaura I, Tani E, Maeda Y, Minami N, Shindo H: Endothelin-1 of canine basilar artery. J Neurosurg 76:99-105, 1992.
141. Yanagisawa M, Masaki T: Molecular biology and biochemistry of the endothelins. Trends Pharmacol Sci 10:374-378, 1989.
142. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kabayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T: A novel potent vasoconstrictor peptide produced by the vascular endothelial cells. Nature 332:411-415, 1988.
143. Yang Z, Richard V, von Segesser L, Bauer E, Stulz P, Turina M, Lüscher TF: Threshold concentrations of endothelin-1 potentiate concentrations to norepinephrine and serotonin in human arteries. Circulation 82:188-195, 1990.
144. Yoshizawa T, Shimni O, Giaid A, Yanagisawa M, Gibson SJ, Kimura S, Uchiyama Y, Polak JM, Masaki T, Kanazawa I: Endothelin: A novel peptide in the posterior pituitary system. Science 247:462-464, 1990.
145. Yoshizumi M, Takaku F, Yanagisawa M, Masaki T, Yazaki Y: Interleukin 1 increases the production of endothelin-1 by cultured endothelial cells. Biochem Biophys Res Commun 166: 324-329, 1990.
146. Zabramski JM, Spetzler RF, Bonstelle C: Chronic cerebral vasospasm: Effect of volume and timing of hemorrhage in a canine model. Neurosurgery 18:1-6, 1986.
147. Zimmermann M, Seifert V: Prevention of cerebral vasospasms after experimental subarachnoid hemorrhage by the endothelin receptor antagonist RO 47-0203 [in German]. Zentralblt Neurochir 57:143-149, 1996.
148. Zimmermann M, Seifert V, Löffler BM, Stolke D, Stenzel W: Prevention of cerebral vasospasm after experimental subarachnoid hemorrhage by RO 47-0203, a potent and orally active endothelin-receptor-antagonist. Neurosurgery 38:115-120, 1996.
149. Ziv I, Flemminger G, Djaldetti R, Achiron A, Melamed E, Sokolovsky M: Increased plasma endothelin-1 in acute ischemic stroke. Stroke 23:1014-1016, 1992.
150. Zuccarello M, Soattin GB, Lewis AI, Breu V, Hallak H, Rapoport RM: Prevention of subarachnoid hemorrhage-induced cerebral vasospasm by oral administration of endothelin receptor antagonists. J Neurosurg 84:503-507, 1996.